|
TRIAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32069910563359E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.90347778942169E-12 |
| Normal-vs-Stage2 |
1.03630000025667E-07 |
| Normal-vs-Stage3 |
4.10810000461836E-08 |
| Normal-vs-Stage4 |
1.131980E-02 |
| Stage1-vs-Stage2 |
2.595800E-01 |
| Stage1-vs-Stage3 |
4.567200E-01 |
| Stage1-vs-Stage4 |
2.623800E-04 |
| Stage2-vs-Stage3 |
1.200580E-01 |
| Stage2-vs-Stage4 |
7.361400E-04 |
| Stage3-vs-Stage4 |
8.422600E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50850451521956E-11 |
| Normal-vs-AfricanAmerican |
8.276400E-03 |
| Normal-vs-Asian |
2.07289999998306E-06 |
| Caucasian-vs-AfricanAmerican |
2.045900E-02 |
| Caucasian-vs-Asian |
2.923800E-01 |
| AfricanAmerican-vs-Asian |
1.886950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91869994839544E-09 |
| Normal-vs-Female |
3.06700220775724E-11 |
| Male-vs-Female |
9.626000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.7610027031908E-11 |
| Normal-vs-Age(41-60Yrs) |
5.21029996924938E-09 |
| Normal-vs-Age(61-80Yrs) |
1.59449999981298E-07 |
| Normal-vs-Age(81-100Yrs) |
1.395830E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.324200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.435800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.456200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.191800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.841000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.207000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.280800E-01 |
| Classical-VS-Follicular |
7.091000E-01 |
| Classical-VS-Other |
7.835800E-01 |
| Classical-VS-Normal |
6.79722944596506E-12 |
| Tall-VS-Follicular |
7.709000E-01 |
| Tall-VS-Other |
8.065800E-01 |
| Tall-VS-Normal |
2.05679999998321E-06 |
| Follicular-VS-Other |
7.309600E-01 |
| Follicular-VS-Normal |
8.37989999946664E-07 |
| Other-VS-Normal |
1.652780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25419682919892E-11 |
| Normal-vs-N1 |
3.816600E-03 |
| N0-vs-N1 |
3.973800E-02 |
|
|
